Form 4: Context Therapeutics CFO Jennifer Lynn Minai-Azary Acquires Stock Options
SEC Form 4 Filing
Jennifer Lynn Minai-Azary, CFO of Context Therapeutics Inc., acquired stock options for 160,115 shares on March 21, 2024.
Summary
- On March 21, 2024, Jennifer Lynn Minai-Azary, the Chief Financial Officer of Context Therapeutics Inc., acquired stock options.
- The stock options grant the right to buy 160,115 shares of common stock at an exercise price of $1.07 per share.
- The options vest over a four-year period, with 25% vesting on March 21, 2025, and the remainder vesting in equal monthly installments over the subsequent three years, contingent upon continued service with the Issuer.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock option grants, which is a common practice. The grant itself can be seen as a positive sign of aligning management interests with shareholders, but it's not a major event.
Positives
- The acquisition of stock options by the CFO aligns her interests with those of the shareholders, incentivizing her to work towards the company's success.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign, aligning the CFO's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/21/2024 | Date of the stock option transaction. |
| 03/21/2025 | Date when 25% of the stock options vest. |
| 03/20/2034 | Expiration date of the stock options. |
| 03/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.